You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IMVT-1401

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graves Disease Trial in Mainz (IMVT-1401 (batoclimab))

Recruiting
  • Graves Disease
  • IMVT-1401 (batoclimab)
  • Mainz, Germany
    Site Number - 6505
Jun 7, 2023

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Boca Raton, Austin (Batoclimab 680 milligrams (mg) subcutaneous (SC)

Recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly
  • +2 more
  • Boca Raton, Florida
  • +1 more
Jan 31, 2023

Generalized Myasthenia Gravis Trial in Carlsbad (Batoclimab 680 mg SC weekly, Batoclimab 340 mg SC weekly, Matching Placebo SC)

Recruiting
  • Generalized Myasthenia Gravis
  • Batoclimab 680 mg SC weekly
  • +3 more
  • Carlsbad, California
  • +14 more
Jan 31, 2023

Myasthenia Gravis Trial in Canada, United States (RVT-1401, Placebo)

Completed
  • Myasthenia Gravis
  • Mobile, Alabama
  • +19 more
Oct 6, 2021

Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via

Terminated
Has Results
  • Graves' Ophthalmopathy (GO)
  • RVT-1401 (Administered via subcutaneous injection)
  • Placebo (Administered via subcutaneous injection)
  • Beverly Hills, California
  • +24 more
Aug 26, 2022

Graves' Ophthalmopathy Trial in Canada (RVT-1401)

Completed
Has Results
  • Graves' Ophthalmopathy
  • Vancouver, British Columbia, Canada
  • +3 more
Dec 24, 2021

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +5 more
  • Tucson, Arizona
  • +16 more
Oct 19, 2022

Warm Autoimmune Hemolytic Anemia Trial in Worldwide (RVT-1401 680 mg/weekly, RVT-1401 340 mg/weekly)

Terminated
Has Results
  • Warm Autoimmune Hemolytic Anemia
  • RVT-1401 680 mg/weekly
  • RVT-1401 340 mg/weekly
  • Iowa City, Iowa
  • +20 more
Jul 1, 2022

Ulcerative Colitis Trial in Whittier (APL-1401, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Whittier, California
    New Hope Research Development
Feb 15, 2023

Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

Completed
Has Results
  • Cutaneous Melanoma
  • +11 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +2 more
  • Chicago, Illinois
  • +6 more
Nov 10, 2021

Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2021

Multiple Myeloma Trial in United States (procedure, drug, biological)

Completed
Has Results
  • Multiple Myeloma
  • Tumor Cell Collection
  • +6 more
  • San Francisco, California
  • +14 more
Jul 11, 2022

Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV Trial in Japan (TBI-1401(HF10), Gemcitabine, Nab-paclitaxel)

Active, not recruiting
  • Pancreatic Cancer Stage III
  • Pancreatic Cancer Stage IV
  • TBI-1401(HF10)
  • +3 more
  • Nagoya, Aichi, Japan
  • +7 more
Mar 31, 2021

Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +2 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2021

Melanoma Trial (omaveloxolone)

No longer available
  • Melanoma
  • (no location specified)
Aug 28, 2020

Melanoma Stage III, Melanoma Stage IV Trial in Japan (TBI-1401(HF10), Ipilimumab)

Completed
  • Melanoma Stage III
  • Melanoma Stage IV
  • Nagakute, Aichi, Japan
  • +11 more
Mar 3, 2020

Acute Myeloid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Buffalo

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 16, 2020

Hypertension With Dyslipidemia Trial in Jeonju (JLP-1401, Telmisartan/Amlodipine, Rosuvastatin)

Completed
  • Hypertension With Dyslipidemia
  • JLP-1401
  • Telmisartan/Amlodipine, Rosuvastatin
  • Jeonju, Korea, Republic of
    Chonbuk National University Hospital
Aug 27, 2019

Breast Cancer, Lung Cancer, Pancreatic Cancer Trial in United States (INO-1400, INO-9012, INO-1401)

Completed
  • Breast Cancer
  • +8 more
  • INO-1400
  • +2 more
  • Detroit, Michigan
  • +5 more
Nov 15, 2018

Hypertension With Dyslipidemia Trial in Jeonju (JLP-1401, Telmisartan/Amlodipine, Rosuvastatin)

Completed
  • Hypertension With Dyslipidemia
  • JLP-1401
  • Telmisartan/Amlodipine, Rosuvastatin
  • Jeonju, Korea, Republic of
    Chonbuk National University Hospital
Dec 21, 2017

Gastritis Acute, Gastritis Chronic Trial (Test(DW1401), Reference(Stillen tab.))

Completed
  • Gastritis Acute
  • Gastritis Chronic
  • (no location specified)
Feb 26, 2018

Pulmonary Alveolar Proteinosis, Autoimmune Trial in Niigata (Sargramostim)

Completed
  • Pulmonary Alveolar Proteinosis, Autoimmune
  • Niigata, Japan
    Niigata University Med & Dental Hospital
Dec 15, 2017

NSCLC Trial in New Haven (CDX-1401, MPDL3280A)

Withdrawn
  • Non-Small Cell Lung Cancer
  • New Haven, Connecticut
    Yale University
Jun 21, 2017

Solid Tumor Trial in Chuo-ku (TBI-1401(HF10))

Completed
  • Solid Tumor
  • TBI-1401(HF10)
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital
Jun 29, 2017

Unresectable Stage III or Stage IV Melanoma Trial in United States (Combination of varlilumab and ipilimumab, Cohort A:

Terminated
  • Unresectable Stage III or Stage IV Melanoma
  • Combination of varlilumab and ipilimumab
  • Cohort A: varlilumab & ipilimumab; Cohort B: varlilumab, ipilimumab, CDX-1401 & poly-ICLC
  • San Francisco, California
  • +7 more
Apr 6, 2017